Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Casey R Dorr

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Med (New York, N.Y.)|August 10, 2024
Opportunities and challenges for immunosuppression in the context of pig-to-human xenotransplantationGuillaume Onyeaghala, Casey R Dorr, Ajay K Israni
Nature Communications|January 31, 2024
Implementing community-engaged pharmacogenomics in Indigenous communitiesKatrina G Claw, Casey R Dorr, Erica L Woodahl
Bioorganic & Medicinal Chemistry Letters|November 19, 2010
Triterpene derivatives that inhibit human immunodeficiency virus type 1 replicationCasey R Dorr, Sergiy Yemets, Oksana Kolomitsyna, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 15, 2017
Genetics of acute rejection after kidney transplantationCasey R Dorr, William S Oetting, Pamala A Jacobson, et al.
Transplantation|February 26, 2019
Analysis of 75 Candidate SNPs Associated With Acute Rejection in Kidney Transplant Recipients: Validation of rs2910164 in MicroRNA MIR146AWilliam S Oetting, David P Schladt, Casey R Dorr, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 24, 2017
CRISPR/Cas9 Genetic Modification of <i>CYP3A5 *3</i> in HuH-7 Human Hepatocyte Cell Line Leads to Cell Lines with Increased Midazolam and Tacrolimus MetabolismCasey R Dorr, Rory P Remmel, Amutha Muthusamy, et al.
Transplantation|February 16, 2024
Pharmacomicrobiomics: Immunosuppressive Drugs and Microbiome Interactions in TransplantationMoataz E Mohamed, Abdelrahman Saqr, Christopher Staley, et al.
Journal of Clinical Pharmacology|January 29, 2021
Precision Dosing for Tacrolimus Using Genotypes and Clinical Factors in Kidney Transplant Recipients of European AncestryMahmoud Al-Kofahi, William S Oetting, David P Schladt, et al.
The Pharmacogenomics Journal|November 17, 2018
Identification of genetic variants associated with tacrolimus metabolism in kidney transplant recipients by extreme phenotype sampling and next generation sequencingCasey R Dorr, Baolin Wu, Rory P Remmel, et al.
Clinical Pharmacokinetics|February 6, 2026
A Mycophenolate Pharmacokinetic Study with New Insights into Enterohepatic Recirculation in Kidney Transplant RecipientsMoataz E Mohamed, Abdelrahman Saqr, Guillaume Onyeaghala, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Med (New York, N.Y.)|August 10, 2024
Opportunities and challenges for immunosuppression in the context of pig-to-human xenotransplantationGuillaume Onyeaghala, Casey R Dorr, Ajay K Israni
Nature Communications|January 31, 2024
Implementing community-engaged pharmacogenomics in Indigenous communitiesKatrina G Claw, Casey R Dorr, Erica L Woodahl
Bioorganic & Medicinal Chemistry Letters|November 19, 2010
Triterpene derivatives that inhibit human immunodeficiency virus type 1 replicationCasey R Dorr, Sergiy Yemets, Oksana Kolomitsyna, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 15, 2017
Genetics of acute rejection after kidney transplantationCasey R Dorr, William S Oetting, Pamala A Jacobson, et al.
Transplantation|February 26, 2019
Analysis of 75 Candidate SNPs Associated With Acute Rejection in Kidney Transplant Recipients: Validation of rs2910164 in MicroRNA MIR146AWilliam S Oetting, David P Schladt, Casey R Dorr, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 24, 2017
CRISPR/Cas9 Genetic Modification of <i>CYP3A5 *3</i> in HuH-7 Human Hepatocyte Cell Line Leads to Cell Lines with Increased Midazolam and Tacrolimus MetabolismCasey R Dorr, Rory P Remmel, Amutha Muthusamy, et al.
Transplantation|February 16, 2024
Pharmacomicrobiomics: Immunosuppressive Drugs and Microbiome Interactions in TransplantationMoataz E Mohamed, Abdelrahman Saqr, Christopher Staley, et al.
Journal of Clinical Pharmacology|January 29, 2021
Precision Dosing for Tacrolimus Using Genotypes and Clinical Factors in Kidney Transplant Recipients of European AncestryMahmoud Al-Kofahi, William S Oetting, David P Schladt, et al.
The Pharmacogenomics Journal|November 17, 2018
Identification of genetic variants associated with tacrolimus metabolism in kidney transplant recipients by extreme phenotype sampling and next generation sequencingCasey R Dorr, Baolin Wu, Rory P Remmel, et al.
Clinical Pharmacokinetics|February 6, 2026
A Mycophenolate Pharmacokinetic Study with New Insights into Enterohepatic Recirculation in Kidney Transplant RecipientsMoataz E Mohamed, Abdelrahman Saqr, Guillaume Onyeaghala, et al.
Pageof 2